Comparing sodium levels in dialysis for ICU patients with kidney injury
Official title: Effects of Variation of Sodium Dialysate in ICU Acute Kiney Injury
Run by University Hospital, Montpellier · NCT03329313 · Data updated 2026-11-12
This study is testing if using a lower sodium level in dialysis can help ICU patients with kidney injury feel more stable and avoid extra fluid buildup.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 158 (estimated) |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 1 site (Montpellier, Montpellier) |
| Status | Recruiting |
| Started | April 19, 2018 |
| Main results expected | December 19, 2026 |
| Study ends | December 19, 2026 |
| Registry record updated | September 30, 2025 |
| Trial ID | NCT03329313 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with acute kidney injury requiring renal replacement therapy and a SOFA score greater than 5.
✕Probably not a fit
Patients with chronic kidney disease stage IV or V, obstructive acute kidney injury, or those who are moribund with a high risk of death within 48 hours may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of different sodium concentrations in dialysate on hemodynamic tolerance and fluid overload in ICU patients suffering from acute kidney injury (AKI) requiring renal replacement therapy. The study compares two groups of patients receiving sustained low efficiency daily dialysis-filtration (SLEDD-f) with dialysate sodium concentrations of 140 mmol/l and 145 mmol/l. The goal is to determine if a lower sodium concentration can maintain hemodynamic stability while reducing the risk of fluid overload, which is associated with higher mortality in critically ill patients. Participants will be monitored over a 7-day period to assess their response to the different sodium levels.
Why it matters
Potential benefit: If successful, this study could lead to improved dialysis protocols that enhance patient safety and outcomes in critically ill patients with AKI.
How similar studies have gone: Previous studies have indicated that varying dialysate sodium concentrations can impact hemodynamic tolerance, suggesting that this approach may yield beneficial results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Age \> 18 years old * Acute kidney injury requiring renal replacement therapy * Dialysis type: on line sustained low efficiency dialy dialysis -filtration * SOFA score \> 5 * Sodium serum level between 135 and 145mmol/l Exclusion criteria: * Chronic kidney disease stade IV ou V * Obstrutive acute kidney injury * Renal tansplantation in the year before ICU admission * Moribund with risk of death in the 48 hours * Vulnerable persons or protected persons * Pregnant or breastfeeding mother
Where it's running
-
Uhmontpellier
Montpellier, Montpellier, France Recruiting
Study contacts
- Principal investigator: vincent BRUNOT, MD — University Hospital, Montpellier
- Study coordinator: vincent BRUNOT, MD
- Email: v-brunot@chu-montpellier.fr
- Phone: 467332495
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FST Decision Support to Help Timely Therapy for Kids with AKI Risk
This study tests whether adding a clinical decision support tool to the electronic medical record helps clinicians use the furosemide stress test in critically ill children at high risk for severe AKI.
-
Epidemiology and care for dialysis in ICU patients with severe acute kidney injury in Latin America
This project will collect and compare data on adults in ICUs across Latin America who need dialysis for severe acute kidney injury to see how they are treated and what outcomes they have.
-
AI software predicting acute kidney injury in ICU patients
This study is testing whether a new AI tool can help doctors predict and prevent kidney problems in ICU patients by alerting them when someone is at high risk.
-
Comparing two methods of renal replacement therapy for patients on ECMO
This study is testing two different ways to provide kidney treatment for patients on ECMO to see which method causes fewer complications like infections and bleeding.
-
Using albumin to improve recovery in critically ill patients with acute kidney injury
This study is testing whether giving critically ill patients with acute kidney injury a special type of albumin instead of regular saline can help them recover better and need less kidney treatment.
-
Remote Ischemic Preconditioning at Different Times After Heart Valve Surgery
This study tests whether applying brief, controlled blood-flow restrictions to a limb at different times after heart valve surgery can help protect organs and reduce complications like kidney injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.